{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T02:55:32Z","timestamp":1785812132514,"version":"3.56.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine and Research"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.resmer.2024.101096","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T09:57:53Z","timestamp":1709200673000},"page":"101096","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Efficacy and safety of different inhaled corticosteroids for bronchopulmonary dysplasia prevention in preterm infants: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"85","author":[{"given":"Minghai","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongqun","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resmer.2024.101096_bib0001","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/sj.jp.7210963","article-title":"Safety, reliability, and validity of a physiologic definition of bronchopulmonary dysplasia","volume":"23","author":"Walsh","year":"2003","journal-title":"J Perinatol"},{"key":"10.1016\/j.resmer.2024.101096_bib0002","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1080\/14767058.2019.1646240","article-title":"Global incidence of bronchopulmonary dysplasia among extremely preterm infants: a systematic literature review","volume":"34","author":"Siffel","year":"2021","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.resmer.2024.101096_bib0003","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/jama.289.9.1124","article-title":"Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms","volume":"289","author":"Schmidt","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.resmer.2024.101096_bib0004","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1542\/peds.2005-2522","article-title":"Bronchopulmonary dysplasia in very low birth weight subjects and lung function in late adolescence","volume":"118","author":"Doyle","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.resmer.2024.101096_bib0005","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/jamapediatrics.2017.5323","article-title":"Cognitive outcomes of children born extremely or very preterm since the 1990s and associated risk factors: a meta-analysis and meta-regression","volume":"172","author":"Twilhaar","year":"2018","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.resmer.2024.101096_bib0006","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1053\/j.semperi.2018.09.013","article-title":"An update on pulmonary and neurodevelopmental outcomes of bronchopulmonary dysplasia","volume":"42","author":"Cheong","year":"2018","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.resmer.2024.101096_bib0007","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.prrv.2010.03.002","article-title":"Acute lung injury in preterm newborn infants: mechanisms and management","volume":"11","author":"Chakraborty","year":"2010","journal-title":"Paediatr Respir Rev"},{"issue":"Suppl 3","key":"10.1016\/j.resmer.2024.101096_bib0008","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1513\/AnnalsATS.201312-424LD","article-title":"Bronchopulmonary dysplasia: NHLBI workshop on the primary prevention of chronic lung diseases","volume":"11","author":"McEvoy","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.resmer.2024.101096_bib0009","article-title":"Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants","volume":"10","author":"Doyle","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.resmer.2024.101096_bib0010","article-title":"Late (\u2265 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants","volume":"11","author":"Doyle","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.resmer.2024.101096_bib0011","article-title":"Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants","author":"Shah","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.resmer.2024.101096_bib0012","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00431-019-03398-5","article-title":"Efficacy and safety of systemic hydrocortisone for the prevention of bronchopulmonary dysplasia in preterm infants: a systematic review and meta-analysis","volume":"178","author":"Morris","year":"2019","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.resmer.2024.101096_bib0013","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.siny.2011.04.007","article-title":"Myth: mechanical ventilation is a therapeutic relic","volume":"16","author":"Gupta","year":"2011","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1016\/j.resmer.2024.101096_bib0014","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000515950","article-title":"Postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia","volume":"118","author":"Doyle","year":"2021","journal-title":"NeonatologyNeonatology"},{"issue":"Suppl 5","key":"10.1016\/j.resmer.2024.101096_bib0015","first-page":"389","article-title":"Intratracheally administered corticosteroids improve lung function in meconium-instilled rabbits","volume":"58","author":"Mokra","year":"2007","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.resmer.2024.101096_bib0016","article-title":"Late (\u2265 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants","volume":"8","author":"Onland","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.resmer.2024.101096_bib0017","article-title":"Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates","volume":"10","author":"Shah","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.resmer.2024.101096_bib0018","article-title":"Inhaled corticosteroids for bronchopulmonary dysplasia: a meta-analysis","volume":"138","author":"Shinwell","year":"2016","journal-title":"PediatricsPediatrics"},{"key":"10.1016\/j.resmer.2024.101096_bib0019","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/ppul.23680","article-title":"Intratracheal administration of budesonide-surfactant in prevention of bronchopulmonary dysplasia in very low birth weight infants: a systematic review and meta-analysis","volume":"52","author":"Venkataraman","year":"2017","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.resmer.2024.101096_bib0020","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ppul.25759","article-title":"Effectiveness and safety of early combined utilization of budesonide and surfactant by airway for bronchopulmonary dysplasia prevention in premature infants with RDS: a meta-analysis","volume":"57","author":"Tang","year":"2022","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.resmer.2024.101096_bib0021","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1002\/ppul.24452","article-title":"Long-term effects of the intratracheal administration of corticosteroids for the prevention of bronchopulmonary dysplasia: a meta-analysis","volume":"54","author":"Zheng","year":"2019","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.resmer.2024.101096_bib0022","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12890-017-0550-z","article-title":"Airway administration of corticosteroids for prevention of bronchopulmonary dysplasia in premature infants: a meta-analysis with trial sequential analysis","volume":"17","author":"Zhang","year":"2017","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.resmer.2024.101096_bib0023","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1056\/NEJMoa1501917","article-title":"Early inhaled budesonide for the prevention of bronchopulmonary dysplasia","volume":"373","author":"Bassler","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resmer.2024.101096_bib0024","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/ppul.25808","article-title":"Corticosteroids in the prevention and treatment of infants with bronchopulmonary dysplasia: part II. Inhaled corticosteroids alone or in combination with surfactants","volume":"57","author":"Szab\u00f3","year":"2022","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.resmer.2024.101096_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.resmer.2024.101096_bib0026","doi-asserted-by":"crossref","DOI":"10.3390\/jcm6010004","article-title":"Bronchopulmonary dysplasia: chronic lung disease of infancy and long-term pulmonary outcomes","volume":"6","author":"Davidson","year":"2017","journal-title":"J Clin Med"},{"key":"10.1016\/j.resmer.2024.101096_bib0027","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.resmer.2024.101096_bib0028","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.resmer.2024.101096_bib0029","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.resmer.2024.101096_bib0030","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/096228020101000402","article-title":"A sensitivity analysis for publication bias in systematic reviews","volume":"10","author":"Copas","year":"2001","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.resmer.2024.101096_bib0031","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval S and Tweedie","year":"2000","journal-title":"BiometricsBiometrics"},{"key":"10.1016\/j.resmer.2024.101096_bib0032","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/(SICI)1099-0496(199604)21:4<231::AID-PPUL5>3.0.CO;2-R","article-title":"Effectiveness of budesonide aerosol in ventilator-dependent preterm babies: a preliminary report","volume":"21","author":"Arnon","year":"1996","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.resmer.2024.101096_bib0033","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1056\/NEJMoa1708831","article-title":"Long-term effects of inhaled budesonide for bronchopulmonary dysplasia","volume":"378","author":"Bassler","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resmer.2024.101096_bib0034","first-page":"25","article-title":"Aerosol inhalation of budesonide and pulmonary surfactant to prevent bronchopulmonary dysplasia","volume":"24","author":"Cao","year":"2018","journal-title":"Journal of Pediatric Pharmacy"},{"key":"10.1016\/j.resmer.2024.101096_bib0035","first-page":"361","article-title":"Effect of budesonide combined with pulmonary surfactant on bronchopulmonary dysplasia in the treatment of severe respiratory distress syndrome","volume":"32","author":"Deng","year":"2017","journal-title":"Chin J Neonatol"},{"key":"10.1016\/j.resmer.2024.101096_bib0036","first-page":"11032","article-title":"Budesonide and Poractant Alfa prevent bronchopulmonary dysplasia via triggering SIRT1 signaling pathway","volume":"23","author":"Du","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.resmer.2024.101096_bib0037","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.5001\/omj.2021.84","article-title":"A randomized clinical trial of intratracheal administration of surfactant and budesonide combination in comparison to surfactant for prevention of bronchopulmonary dysplasia","volume":"36","author":"Gharehbaghi","year":"2021","journal-title":"Oman Med J"},{"key":"10.1016\/j.resmer.2024.101096_bib0038","doi-asserted-by":"crossref","first-page":"551","DOI":"10.24953\/turkjped.2020.04.004","article-title":"Intratracheal administration of budesonide with surfactant in very low birth weight infants to prevent bronchopulmonary dysplasia","volume":"62","author":"Heo","year":"2020","journal-title":"Turk J Pediatr"},{"key":"10.1016\/j.resmer.2024.101096_bib0039","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/j.1651-2227.2000.tb02775.x","article-title":"Budesonide delivered by dosimetric jet nebulization to preterm very low birthweight infants at high risk for development of chronic lung disease","volume":"89","author":"J\u00f3nsson","year":"2000","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.resmer.2024.101096_bib0040","first-page":"400","article-title":"[Efficacy of different preparations of budesonide combined with pulmonary surfactant in the treatment of neonatal respiratory distress syndrome: a comparative analysis]","volume":"18","author":"Ke","year":"2016","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"10.1016\/j.resmer.2024.101096_bib0041","first-page":"53","article-title":"Effect of intratracheal administration of pulmonary surfactant plus budesonide on bronchopulmonary dysplasia in premature infants","volume":"14","author":"Kou","year":"2019","journal-title":"China Medicine"},{"key":"10.1016\/j.resmer.2024.101096_bib0042","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jpeds.2009.10.049","article-title":"A follow-up study of preterm infants given budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants","volume":"156","author":"Kuo","year":"2010","journal-title":"J Pediatr"},{"key":"10.1016\/j.resmer.2024.101096_bib0043","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000014076","article-title":"Inhaled budesonide in ventilator-dependent preterm infants: a randomized, double-blind pilot study","volume":"75","author":"Merz","year":"1999","journal-title":"Biol Neonate"},{"key":"10.1016\/j.resmer.2024.101096_bib0044","first-page":"137","article-title":"[Clinical efficacy of pulmonary surfactant combined with budesonide for preventing bronchopulmonary dysplasia in very low birth weight infants]","volume":"19","author":"Pan","year":"2017","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"10.1016\/j.resmer.2024.101096_bib0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/ijpvm.IJPVM_336_16","article-title":"The effect of inhaled budesonide on the prevention of chronic lung disease in premature neonates with respiratory distress syndrome","volume":"9","author":"Sadeghnia","year":"2018","journal-title":"Int J Prev Med"},{"key":"10.1016\/j.resmer.2024.101096_bib0046","first-page":"2121","article-title":"Effect of Budesonide suspension oxygenation atomization inhalation on prevention and treatment of bronchopulmonary dysplasia in pre-mature infants","volume":"18","author":"Wang","year":"2019","journal-title":"J Clin Experimental Med"},{"key":"10.1016\/j.resmer.2024.101096_bib0047","first-page":"85","article-title":"Clinical observation of budesonide suspension preventing premature infants with bronchopulmonary dysplasia","volume":"16","author":"Wen","year":"2016","journal-title":"World Latest Med Inf"},{"key":"10.1016\/j.resmer.2024.101096_bib0048","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1164\/rccm.201505-0861OC","article-title":"Intratracheal administration of budesonide\/surfactant to prevent bronchopulmonary dysplasia","volume":"193","author":"Yeh","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resmer.2024.101096_bib0049","doi-asserted-by":"crossref","first-page":"e1310","DOI":"10.1542\/peds.2007-1973","article-title":"Early intratracheal instillation of budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants: a pilot study","volume":"121","author":"Yeh","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.resmer.2024.101096_bib0050","first-page":"27","article-title":"Effects of budesonide combined with pulmonary surfactant on short-term efficacy, blood oxygenation index and \u0f51\u0fb7isk of bronchopulmonary dysplasia in premature infants with severe \u0f51\u0fb7espiratory distress syndrome","volume":"25","author":"Zhou","year":"2019","journal-title":"J Pediatric Pharmacy"},{"key":"10.1016\/j.resmer.2024.101096_bib0051","first-page":"252","article-title":"Effect of budesonide on pulmonary surfactant in treating neonatal respiratory distress syndrome","volume":"27","author":"Chen","year":"2020","journal-title":"Chin J Pharmaceut Biotechnol"},{"key":"10.1016\/j.resmer.2024.101096_bib0052","first-page":"796","article-title":"Effect of budesonide combined with pulmonary surfactant on prevention of bronchopulmonary dysplasia in premature infants","volume":"20","author":"Luo","year":"2018","journal-title":"Zhejiang Clin Med J"},{"key":"10.1016\/j.resmer.2024.101096_bib0053","first-page":"154","article-title":"Influence of combined drug therapy by intratracheal infusion on clinical prognosis of premature infants with severe RDS","volume":"42","author":"Ping","year":"2019","journal-title":"Chin J Postgraduates Med"},{"key":"10.1016\/j.resmer.2024.101096_bib0054","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1002\/ppul.24704","article-title":"Early inhaled budesonide in extremely preterm infants decreases long-term respiratory morbidity","volume":"55","author":"Tukova","year":"2020","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.resmer.2024.101096_bib0055","first-page":"33","article-title":"Pulmonary surfactant in combination with intratracheal budesonide instillation for treatment of respiratory distress syndrome in preterm infants: a randomized controlled trial","volume":"36","author":"Yang","year":"2021","journal-title":"Chin J Neonatol"},{"key":"10.1016\/j.resmer.2024.101096_bib0056","first-page":"4949","article-title":"Efficacy of budesonide in the prevention and treatment of bronchopulmonary dysplasia in premature infants and its effect on pulmonary function","volume":"13","author":"Yao","year":"2021","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.resmer.2024.101096_bib0057","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJM199904013401304","article-title":"Early inhaled glucocorticoid therapy to prevent bronchopulmonary dysplasia","volume":"340","author":"Cole","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resmer.2024.101096_bib0058","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1007\/s004310050969","article-title":"Inhaled salbutamol and beclomethasone for preventing broncho-pulmonary dysplasia: a randomised double-blind study","volume":"157","author":"Denjean","year":"1998","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.resmer.2024.101096_bib0059","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/pch\/7.1.13","article-title":"Early prophylactic inhaled beclomethasone in infants less than 1250g for the prevention of chronic lung disease","volume":"7","author":"Jangaard","year":"2002","journal-title":"Paediatr Child Health"},{"key":"10.1016\/j.resmer.2024.101096_bib0060","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0022-3476(06)80134-4","article-title":"Controlled trial of beclomethasone dipropionate by nebulization in oxygen- and ventilator-dependent infants","volume":"122","author":"LaForce","year":"1993","journal-title":"J Pediatr"},{"key":"10.1016\/j.resmer.2024.101096_bib0061","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/00130478-200010000-00009","article-title":"Meter-dosed, inhaled beclomethasone initiated at birth to prevent bronchopulmonary dysplasia","volume":"1","author":"Zimmerman","year":"2000","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.resmer.2024.101096_bib0062","doi-asserted-by":"crossref","first-page":"F203","DOI":"10.1136\/fn.80.3.F203","article-title":"Randomised controlled study of early use of inhaled corticosteroid in preterm infants with respiratory distress syndrome","volume":"80","author":"Fok","year":"1999","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.resmer.2024.101096_bib0063","doi-asserted-by":"crossref","first-page":"F552","DOI":"10.1136\/archdischild-2015-309943","article-title":"Early inhaled steroid use in extremely low birthweight infants: a randomised controlled trial","volume":"101","author":"Nakamura","year":"2016","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.resmer.2024.101096_bib0064","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s11596-019-2064-9","article-title":"Early intratracheal administration of corticosteroid and pulmonary surfactant for preventing bronchopulmonary dysplasia in preterm infants with neonatal respiratory distress syndrome: a meta-analysis","volume":"39","author":"Zhong","year":"2019","journal-title":"Curr Med Sci"},{"key":"10.1016\/j.resmer.2024.101096_bib0065","doi-asserted-by":"crossref","first-page":"F137","DOI":"10.1136\/archdischild-2017-314046","article-title":"Efficacy and safety of pulmonary application of corticosteroids in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis","volume":"104","author":"Delara","year":"2019","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.resmer.2024.101096_bib0066","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-3659(99)00230-8","article-title":"Drug solubilization in lung surfactant","volume":"65","author":"Wiedmann","year":"2000","journal-title":"J Control Release"},{"key":"10.1016\/j.resmer.2024.101096_bib0067","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1165\/rcmb.2016-0068OC","article-title":"Antiinflammatory effects of budesonide in human fetal lung","volume":"55","author":"Barrette","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.resmer.2024.101096_bib0068","article-title":"Intratracheal administration of budesonide within seven days after birth for preventing bronchopulmonary dysplasia in preterm infants:a systematic review and meta-analysis","author":"Chen","year":"2016","journal-title":"Chin J Evidence-Based Pediatrics"},{"key":"10.1016\/j.resmer.2024.101096_bib0069","series-title":"Double-blind controlled trial of endotracheal instillation of budesonide in preterm infants with RDS-A preliminary report","author":"Lin","year":"2000"},{"key":"10.1016\/j.resmer.2024.101096_bib0070","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12887-018-1134-7","article-title":"Inhaled corticosteroids in ventilated preterm neonates: a non-randomized dose-ranging study","volume":"18","author":"Raghuram","year":"2018","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.resmer.2024.101096_bib0071","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1001\/jamapediatrics.2021.5111","article-title":"Inhaled corticosteroids alone and in combination with long-acting \u03b22 receptor agonists to treat reduced lung function in preterm-born children: a randomized clinical trial","volume":"176","author":"Goulden","year":"2022","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.resmer.2024.101096_bib0072","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9051539","article-title":"Present and future of bronchopulmonary dysplasia","volume":"9","author":"Bonadies","year":"2020","journal-title":"J Clin Med"}],"container-title":["Respiratory Medicine and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590041224000138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590041224000138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T23:31:24Z","timestamp":1715643084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590041224000138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":72,"alternative-id":["S2590041224000138"],"URL":"https:\/\/doi.org\/10.1016\/j.resmer.2024.101096","relation":{},"ISSN":["2590-0412"],"issn-type":[{"value":"2590-0412","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of different inhaled corticosteroids for bronchopulmonary dysplasia prevention in preterm infants: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine and Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resmer.2024.101096","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 SPLF and Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101096"}}